PYRIMIDINYL GROUP-CONTAINING TRICYCLIC COMPOUND SERVING AS C-MET INHIBITOR
Disclosed are a pyrimidinyl group-containing tricyclic compound and applications thereof in preparing a cancer-treating medicament. Specifically disclosed are a compound as represented by formula (I), a pharmaceutically acceptable salt of same, or an isomer thereof.
-
Paragraph 0550-0552
(2021/12/18)
New azetidine-3-carbonyl-N-methyl-hydrazino derivatives of fluoroquinolones: Synthesis and evaluation of antibacterial and anticancer properties
A series of nine new N-(substituted azetidine-3-carbonyl)-N-methyl-hydrazino derivatives at C-7 position of fluoroquinolones were designed and synthesized through multistep synthesis. The synthesized compounds were characterized by 1H NMR, sup
Rajulu, G. Govinda,Naik, Halehatty S. Bhojya,Kumar, G. Charan,Ramaraj,Sambasivam, Ganesh,Koppolu, Kesavan Poonimangadu
p. 2856 - 2868
(2016/02/10)
NEW TETRACYCLINE DERIVATIVES AS ANTIINFECTIVE AGENTS
In accordance with one embodiment, the present invention provides a compound of general formula (I), stereoisomers thereof and/or its pharmaceutically acceptable salts thereof, which have antibacterial activity; with methods of treating infectious diseases in warm blooded animals employing these new compounds.
-
Page/Page column 29
(2009/04/25)
More Articles about upstream products of 959238-28-9